The questions/answers should all be updated. Please note, I have not edited the questions/answers to incorporate the data that came out of ASCO 2018.
I am waiting to see if things get FDA approved and/or adopted by the NCCN guidelines first prior to editing certain questions. As an example, I have a question that Pembrolizumab is approved as frontline monotherapy for Metastatic lung cancer if the PD-L1 is >/=50%. Data now suggests that if the PD-L1 is >/= 1% that Pembrolizumab (as monotherapy) is more effective than chemotherapy as frontline therapy. If/when this gets adopted as standard practice, I will edit this particular question (and with others as new data emerges).
The App is now available for both the iPhone and Android. It is part of the subscription (it is not an additional cost)
If any glitches or errors are found, please let me know. Also, if you disagree with a question/answer, I would love to hear your thoughts. Please email me at email@example.com
166 New Hematology/Oncology questions/answers have now been added in various categories including:
CLL and other Leukemias
White cell and bone marrow disorders
Anemia and Growth factors
This website will not work well on Internet Explorer 8 (in fact, if you have Internet Explorer 8, you may not be able to sign up or take the free demo). The website will work well on Internet Explorer 9 and above versions.
If you register and do not receive a password, please check the Spam section of your email. If there are any issues or problems registering for the site, please email us at firstname.lastname@example.org and We will help out.
Internet Explorer is still the browser that is found on many hospital computers. Please check the tab 'System Requirements' so you can download one of 4 updated browsers to access this website